MediWound: New Insider Vickie Rae Driver Files Initial Ownership (Form 3)

TL;DR

**New insider Vickie Rae Driver just filed her initial ownership statement for MediWound (MDWD).**

AI Summary

Vickie Rae Driver, a new insider at MediWound Ltd. (NASDAQ: MDWD), filed a Form 3 on March 25, 2026, indicating her initial beneficial ownership of securities as of March 18, 2026. This filing is a standard requirement for new officers, directors, or significant shareholders, establishing a baseline for future transactions. For investors, this matters because it signals a new individual has taken on a role that requires disclosure of their holdings, providing transparency into potential future insider activity.

Why It Matters

This filing introduces a new insider, Vickie Rae Driver, to MediWound's ownership structure, providing transparency into her initial holdings and setting the stage for future disclosures of her transactions.

Risk Assessment

Risk Level: low — This is a routine compliance filing for a new insider and does not inherently indicate any positive or negative financial risk.

Analyst Insight

Investors should note the introduction of Vickie Rae Driver as an insider and monitor future Form 4 filings for any significant buying or selling activity, which could provide insights into management's confidence in MediWound Ltd.'s prospects.

Key Players & Entities

• Vickie Rae Driver (person) — Reporting Person
• MediWound Ltd. (company) — Issuer
• 0002123640 (person) — Vickie Rae Driver's CIK
• 0001593984 (company) — MediWound Ltd.'s CIK

Forward-Looking Statements

• Vickie Rae Driver will file future Form 4s to report changes in her beneficial ownership of MediWound Ltd. securities. (Vickie Rae Driver) — high confidence, target: Ongoing

FAQ

Filing Documents

• ownership.html (3)
• ownership.xml (3) — 10KB
• ex24-1.htm (EX-24.1) — 7KB
• 0001178913-26-001689.txt ( ) — 18KB

From the Filing

SEC FORM 3 SEC Form 3 FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5 1. Name and Address of Reporting Person * Driver Vickie Rae (Last) (First) (Middle) C/O MEDIWOUND LTD. 42 HAYARKON STREET (Street) YAVNE 8122745 (City) (State) (Zip) ISRAEL (Country) 2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026 3. Issuer Name and Ticker or Trading Symbol MediWound Ltd. [ MDWD ] 3a. Foreign Trading Symbol 5. If Amendment, Date of Original Filed (Month/Day/Year) 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person Table I - Non-Derivative Securities Beneficially Owned 1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Ordinary shares 1,910 D Ordinary shares (1) 750 D Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (right to buy ordinary shares) 06/29/2021 06/29/2030 Ordinary shares 14,285 $ 12.25 D Stock Option (right to buy ordinary shares) 06/15/2022 06/15/2031 Ordinary shares 1,607 $ 37.52 D Stock Option (right to buy ordinary shares) 05/16/2023 05/16/2032 Ordinary shares 5,357 $ 14.42 D Stock Option (right to buy ordinary shares) 05/31/2024 05/30/2033 Ordinary shares 5,900 $ 11.885 D Stock Option (right to buy ordinary shares) 02/26/2025 02/26/2034 Ordinary shares 7,542 $ 12.729 D Stock Option (right to buy ordinary shares) 02/11/2026 02/11/2035 Ordinary shares 5,600 $ 18.54 D Stock Option (right to buy ordinary shares) (2) 03/04/2036 Ordinary shares 6,250 $ 17.6 D Explanation of Responses: 1. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date. 2. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date. /s/ Yaron Meyer, attorney-in-fact 03/25/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 3: SEC 1473 (03-26)

View Full Filing

View this 3 filing on SEC EDGAR